ArticleMedical & biological engineering & computing2025
Closed loop automated drug infusion regulation based on optimal 2-DOF TID control approach for the mean arterial blood pressure.
Article in Medical & biological engineering & computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work aims to design an optimal controller for regulating mean arterial blood pressure (MAP) during the cardiac cycle in surgical and post-surgical conditions to enhance automated drug infusion. MAP controllers must address uncertainties like external disturbances, time-varying parameters, and noise. Thus, closed-loop control is essential to normalize MAP regardless of the patient's pharmacokinetics during surgery. A two-degree-of-freedom tilt integral derivative (2-DOF TID) controller, tuned by the Chernobyl Disaster Optimizer (CDO) algorithm, is proposed to dynamically adjust sodium nitroprusside (SNP) infusion rates in various conditions. The performance of this 2-DOF TID controller is compared with CDO-based PID, 2-DOF PID, and TID controllers. The results demonstrate the effectiveness and robustness of the proposed controller in achieving and maintaining MAP at 100 mmHg. All controllers are evaluated on different patient responses, including fixed and time-varying sensitivities, to SNP infusion, external disturbances, and noise. The study reveals which controller performs best in terms of overshoot, settling time, error, disturbance rejection, and anti-interference ability, confirming the 2-DOF TID controller as a strong candidate for automated drug infusion systems in clinical settings.
Indexed as
Identifiers
39924619What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.